Ovid Therapeutics (OVID) Short Interest Ratio & Short Volume $1.06 -0.09 (-7.83%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Ovid Therapeutics Short Interest DataOvid Therapeutics (OVID) has a short interest of 679,900 shares, representing 1.16% of the float (the number of shares available for trading by the public). This marks a 12.03% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.8, indicating that it would take 3.8 days of the average trading volume of 204,800 shares to cover all short positions.Current Short Interest679,900 sharesPrevious Short Interest606,900 sharesChange Vs. Previous Month+12.03%Dollar Volume Sold Short$768,287.00Short Interest Ratio3.8 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares71,010,000 sharesFloat Size58,430,000 sharesShort Percent of Float1.16%Today's Trading Volume437,654 sharesAverage Trading Volume204,800 sharesToday's Volume Vs. Average214% Short Selling Ovid Therapeutics? Sign up to receive the latest short interest report for Ovid Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOVID Short Interest Over TimeOVID Days to Cover Over TimeOVID Percentage of Float Shorted Over Time Ad Genesis Gold GroupTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov Ovid Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024679,900 shares $768,287.00 +12.0%1.2%3.8 $1.13 10/15/2024606,900 shares $697,935.00 -4.3%1.0%3.4 $1.15 9/30/2024633,900 shares $748,002.00 -3.1%1.1%2.8 $1.18 9/15/2024653,900 shares $778,141.00 -9.3%1.1%1.4 $1.19 8/31/2024721,300 shares $815,069.00 -10.2%1.2%0.8 $1.13 8/15/2024803,200 shares $907,616.00 -24.9%1.4%0.9 $1.13 Get the Latest News and Ratings for OVID and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/20241,070,000 shares $1.11 million -2.7%1.9%1.2 $1.04 7/15/20241,100,000 shares $1.03 million +6.8%1.9%1.3 $0.94 6/30/20241,030,000 shares $792,276.00 -64.0%1.8%1.2 $0.77 6/15/20242,860,000 shares $9.41 million -0.4%5.0%4.1 $3.29 5/31/20242,870,000 shares $8.78 million +0.7%5.0%15.2 $3.06 5/15/20242,850,000 shares $9.46 million +1.1%5.0%14.6 $3.32 4/30/20242,820,000 shares $8.60 million +0.7%4.8%13.7 $3.05 4/15/20242,800,000 shares $8.96 million No Change4.8%13.4 $3.20 3/31/20242,800,000 shares $8.54 million -23.7%4.8%13.7 $3.05 3/15/20243,670,000 shares $9.98 million +0.6%6.3%17.4 $2.72 2/29/20243,650,000 shares $12.41 million +1.4%6.2%22.9 $3.40 2/15/20243,600,000 shares $13.10 million +7.8%6.1%23.9 $3.64 1/31/20243,340,000 shares $12.93 million +8.4%5.6%23.5 $3.87 1/15/20243,080,000 shares $9.64 million +6.2%5.2%21.9 $3.13 12/31/20232,900,000 shares $9.34 million +16.9%4.9%21.3 $3.22 12/15/20232,480,000 shares $8.53 million +7.8%4.2%18.2 $3.44 11/30/20232,300,000 shares $6.84 million +7.5%3.9%19.2 $2.98 11/15/20232,140,000 shares $7.19 million +6.5%3.7%18 $3.36 10/31/20232,010,000 shares $7.14 million +2.6%3.5%13.2 $3.55 10/15/20231,960,000 shares $7.19 million -5.3%3.4%12.3 $3.67 9/30/20232,070,000 shares $7.95 million +2.0%3.6%13.4 $3.84 9/15/20232,030,000 shares $8.06 million -2.4%3.5%11.9 $3.97 8/31/20232,080,000 shares $7.00 million +12.4%3.6%6.6 $3.37 8/15/20231,850,000 shares $6.64 million +1.1%3.2%5.9 $3.59 7/31/20231,830,000 shares $6.57 million -0.5%3.1%6.3 $3.59 7/15/20231,840,000 shares $6.24 million No Change3.3%6.4 $3.39 6/30/20231,840,000 shares $6.04 million +216.7%3.3%6.4 $3.28 6/15/2023581,000 shares $2.08 million +40.2%1.0%2.2 $3.58 5/31/2023414,500 shares $1.47 million +28.7%0.7%3.3 $3.54 5/15/2023322,100 shares $1.12 million +62.3%0.6%3.2 $3.49 4/30/2023198,500 shares $710,630.00 -7.2%0.4%2.2 $3.58 4/15/2023213,900 shares $663,090.00 +2.6%0.4%2.9 $3.10 3/31/2023208,500 shares $537,930.00 -9.8%0.4%3 $2.58 3/15/2023231,200 shares $483,208.00 -5.5%0.4%3.3 $2.09Trump’s Back, but DC’s Coming for Your Money! (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov 2/28/2023244,600 shares $604,162.00 +9.1%0.4%2.7 $2.47 2/15/2023224,300 shares $567,479.00 -1.1%0.4%2.6 $2.53 1/31/2023226,700 shares $566,750.00 +3.1%0.4%2.6 $2.50 1/15/2023219,800 shares $523,124.00 +2.9%0.4%2.5 $2.38 12/30/2022213,600 shares $397,296.00 -24.7%0.4%1.8 $1.86 12/15/2022283,500 shares $510,300.00 +4.5%0.5%2.4 $1.80 11/30/2022271,200 shares $480,024.00 -5.8%0.5%2.6 $1.77 11/15/2022287,800 shares $483,504.00 +3.6%0.5%2.8 $1.68 10/31/2022277,700 shares $452,651.00 -3.7%0.5%2.6 $1.63 10/15/2022288,300 shares $449,748.00 +1.8%0.5%2.6 $1.56 9/30/2022283,100 shares $520,904.00 +1.9%0.5%3.1 $1.84 9/15/2022277,800 shares $608,382.00 -3.5%0.5%2.7 $2.19 8/31/2022287,800 shares $578,478.00 +2.5%0.5%2.1 $2.01 8/15/2022280,800 shares $634,608.00 -6.8%0.5%1.6 $2.26 7/31/2022301,200 shares $617,460.00 -11.7%0.5%1.7 $2.05 7/15/2022341,100 shares $689,022.00 -6.9%0.7%1.9 $2.02 6/30/2022366,400 shares $787,760.00 -9.4%0.7%2 $2.15 6/15/2022404,500 shares $728,100.00 -31.7%0.8%2.1 $1.80 5/31/2022592,200 shares $1.00 million -5.5%1.1%3.3 $1.69 5/15/2022626,400 shares $1.37 million -6.9%1.2%3.9 $2.19 4/30/2022672,700 shares $1.85 million -5.6%1.3%4.4 $2.75 4/15/2022712,800 shares $2.29 million -3.0%1.4%3.9 $3.21 3/31/2022735,000 shares $2.31 million +0.3%1.4%3.7 $3.14 3/15/2022733,000 shares $2.29 million +5.3%1.4%3.7 $3.13 2/28/2022696,000 shares $2.36 million +7.2%1.4%3.2 $3.39 2/15/2022649,000 shares $2.08 million -9.2%1.3%3 $3.21 1/31/2022715,000 shares $1.97 million -0.5%1.4%3.1 $2.76 1/15/2022718,800 shares $2.25 million -3.9%1.5%3.3 $3.13 12/31/2021748,200 shares $2.40 million +4.1%1.5%3.6 $3.21 12/15/2021718,600 shares $2.31 million -4.1%1.5%3.1 $3.21 11/30/2021749,200 shares $2.51 million +13.0%1.5%3.4 $3.35 11/15/2021663,000 shares $2.41 million -39.2%1.3%2.7 $3.64 10/29/20211,090,000 shares $3.71 million -4.4%2.2%4.1 $3.40 10/15/20211,140,000 shares $4.10 million +10.7%2.3%4.1 $3.60 9/30/20211,030,000 shares $3.46 million -13.5%2.1%3.4 $3.36 9/15/20211,190,000 shares $4.12 million -26.5%2.5%2.7 $3.46 8/31/20211,620,000 shares $5.72 million -4.1%3.5%3.1 $3.53 8/13/20211,690,000 shares $6.83 million +3.7%3.6%2.8 $4.04 7/30/20211,630,000 shares $6.08 million -1.2%3.5%2.4 $3.73 7/15/20211,650,000 shares $6.09 million -1.2%3.5%2.2 $3.69 6/30/20211,670,000 shares $6.53 million -52.6%3.6%2 $3.91 6/15/20213,520,000 shares $15.52 million +0.6%6.5%4.4 $4.41 5/28/20213,500,000 shares $14.53 million -6.2%6.5%3.7 $4.15 5/14/20213,730,000 shares $12.31 million -11.8%N/A1.2 $3.30 4/30/20214,230,000 shares $16.37 million -10.2%N/A1.2 $3.87 4/15/20214,710,000 shares $18.13 million -18.5%N/A1.2 $3.85 3/31/20215,780,000 shares $22.25 million -29.1%N/A1.4 $3.85 3/15/20218,150,000 shares $33.42 million +153.1%N/A2 $4.10 2/26/20213,220,000 shares $9.50 million +17.1%8.4%0.7 $2.95 2/12/20212,750,000 shares $9.19 million -6.5%7.2%1.2 $3.34“This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! 1/29/20212,940,000 shares $7.67 million -8.4%8.2%1.4 $2.61 1/15/20213,210,000 shares $8.25 million -7.2%8.9%1.8 $2.57 12/31/20203,460,000 shares $8.23 million -10.1%9.6%2.3 $2.38 12/15/20203,850,000 shares $10.16 million +11.3%10.7%2.8 $2.64 11/30/20203,460,000 shares $21.76 million +13.4%9.6%3.1 $6.29 11/15/20203,050,000 shares $18.42 million +15.1%8.5%3.2 $6.04 10/30/20202,650,000 shares $13.91 million +0.8%6.9%2.8 $5.25 10/15/20202,630,000 shares $14.96 million -38.0%6.9%2.7 $5.69 9/30/20204,240,000 shares $24.34 million +20.8%11.1%4.2 $5.74 9/15/20203,510,000 shares $22.50 million -22.5%9.9%2.9 $6.41 8/31/20204,530,000 shares $26.00 million +51.0%12.7%2.8 $5.74 8/14/20203,000,000 shares $22.50 million +2.7%9.7%1.8 $7.50 7/31/20202,920,000 shares $18.83 million +15.4%9.5%2 $6.45 7/15/20202,530,000 shares $18.60 million -30.1%8.6%1.7 $7.35 6/30/20203,620,000 shares $26.68 million +170.2%12.3%2.5 $7.37 6/15/20201,340,000 shares $7.60 million +58.6%4.6%1.1 $5.67 5/29/2020844,800 shares $4.52 million -37.4%2.9%1 $5.35 5/15/20201,350,000 shares $5.55 million -18.2%4.6%1.7 $4.11 4/30/20201,650,000 shares $6.01 million +20.4%5.7%2.7 $3.64 4/15/20201,370,000 shares $4.64 million +8.7%4.7%2.5 $3.39 3/31/20201,260,000 shares $4.30 million -43.2%4.4%2.2 $3.41 3/13/20202,216,300 shares $6.29 million +21.8%9.8%3.5 $2.84 2/28/20201,820,000 shares $4.40 million +94.6%8.0%2.7 $2.42 2/14/2020935,500 shares $2.88 million -14.2%4.2%1.3 $3.08 1/31/20201,090,000 shares $3.52 million +27.0%5.1%1.5 $3.23 1/15/2020858,500 shares $3.41 million +5.8%4.0%1.2 $3.97 12/31/2019811,800 shares $2.88 million +234.6%3.6%1.2 $3.55 OVID Short Interest - Frequently Asked Questions What is Ovid Therapeutics' current short interest? Short interest is the volume of Ovid Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 679,900 shares of OVID short. 1.16% of Ovid Therapeutics' shares are currently sold short. Learn More on Ovid Therapeutics' current short interest. What is a good short interest ratio for Ovid Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OVID shares currently have a short interest ratio of 4.0. Learn More on Ovid Therapeutics's short interest ratio. What is a good short interest percentage for Ovid Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.16% of Ovid Therapeutics' floating shares are currently sold short. Is Ovid Therapeutics' short interest increasing or decreasing? Ovid Therapeutics saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 679,900 shares, an increase of 12.0% from the previous total of 606,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ovid Therapeutics' float size? Ovid Therapeutics currently has issued a total of 71,010,000 shares. Some of Ovid Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ovid Therapeutics currently has a public float of 58,430,000 shares. How does Ovid Therapeutics' short interest compare to its competitors? 1.16% of Ovid Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ovid Therapeutics: Immunic, Inc. (5.00%), TherapeuticsMD, Inc. (0.26%), Sage Therapeutics, Inc. (11.91%), COMPASS Pathways plc (7.97%), YS Biopharma Co., Ltd. (0.20%), Alpha Teknova, Inc. (2.71%), iTeos Therapeutics, Inc. (11.11%), Sutro Biopharma, Inc. (2.91%), SNDL Inc. (1.85%), uniQure (7.39%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Ovid Therapeutics stock? Short selling OVID is an investing strategy that aims to generate trading profit from Ovid Therapeutics as its price is falling. OVID shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ovid Therapeutics? A short squeeze for Ovid Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OVID, which in turn drives the price of the stock up even further. How often is Ovid Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OVID, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies IMUX Short Squeeze TXMD Short Squeeze SAGE Short Squeeze CMPS Short Squeeze YSB Short Squeeze TKNO Short Squeeze ITOS Short Squeeze STRO Short Squeeze SNDL Short Squeeze QURE Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OVID) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ovid Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ovid Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OVID Stock Alerts